SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUIDOBONI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.481
NA - Nord America 1.153
EU - Europa 425
SA - Sud America 265
AF - Africa 33
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.360
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.099
SG - Singapore 767
CN - Cina 307
BR - Brasile 214
HK - Hong Kong 182
IT - Italia 135
VN - Vietnam 95
DE - Germania 74
UA - Ucraina 45
ID - Indonesia 43
RU - Federazione Russa 36
GB - Regno Unito 32
MX - Messico 28
AR - Argentina 26
IN - India 26
CA - Canada 20
ZA - Sudafrica 18
AT - Austria 14
FR - Francia 13
NL - Olanda 13
BD - Bangladesh 12
PL - Polonia 12
FI - Finlandia 11
EC - Ecuador 9
TR - Turchia 9
ES - Italia 8
SE - Svezia 8
LT - Lituania 7
AE - Emirati Arabi Uniti 5
PK - Pakistan 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
CO - Colombia 4
EG - Egitto 4
JP - Giappone 4
KE - Kenya 4
CL - Cile 3
IL - Israele 3
IQ - Iraq 3
PH - Filippine 3
SA - Arabia Saudita 3
CH - Svizzera 2
JO - Giordania 2
KH - Cambogia 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
IE - Irlanda 1
KG - Kirghizistan 1
KI - Kiribati 1
LU - Lussemburgo 1
MN - Mongolia 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.360
Salva come PNG Salva come JPEG
Città #
Singapore 405
Santa Clara 267
Hong Kong 182
Ashburn 138
Beijing 85
Los Angeles 44
Ho Chi Minh City 39
Jakarta 39
Houston 37
Woodbridge 37
Fairfield 36
Jacksonville 27
Dallas 26
Chicago 24
São Paulo 24
Hefei 22
Nuremberg 22
Mexico City 21
Ferrara 20
New York 20
Bologna 17
Hanoi 17
Dearborn 16
Milan 16
Seattle 14
Shanghai 14
Warsaw 12
San Francisco 11
Cambridge 10
Chandler 10
Falkenstein 10
Wilmington 10
Atlanta 9
Brooklyn 8
Rio de Janeiro 8
Boardman 7
Chennai 7
Orem 7
Toronto 7
Curitiba 6
Denver 6
Johannesburg 6
London 6
Nanjing 6
Vienna 6
Amsterdam 5
Boston 5
Guarulhos 5
Izmir 5
Manchester 5
Montreal 5
Nanchang 5
Princeton 5
Rome 5
Salt Lake City 5
San Diego 5
Ann Arbor 4
Assago 4
Belo Horizonte 4
Biên Hòa 4
Buffalo 4
Forlì 4
Guangzhou 4
Guayaquil 4
Hải Dương 4
Lappeenranta 4
Moscow 4
Munich 4
Phoenix 4
Stockholm 4
Tokyo 4
Baghdad 3
Banja Luka 3
Brasília 3
Buenos Aires 3
Bình Dương 3
Caxias do Sul 3
Cleveland 3
Delhi 3
Frankfurt am Main 3
Hortolândia 3
Manila 3
Mumbai 3
Newark 3
Parma 3
Poplar 3
Primavera do Leste 3
San Jose 3
Shijiazhuang 3
Tampa 3
Abu Dhabi 2
Amman 2
Araruama 2
Asunción 2
Bagé 2
Bari 2
Barra Mansa 2
Belgrade 2
Brescia 2
Brookline 2
Totale 1.953
Salva come PNG Salva come JPEG
Nome #
The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up 155
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 150
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 124
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 110
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma 95
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 91
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 90
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 77
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis 69
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 69
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 64
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 60
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial 60
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 59
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 58
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions 57
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 57
Dabrafenib-trametinib combination in 'field-practice': an Italian experience 53
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience 53
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 53
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 53
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 53
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study 52
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial 52
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 52
First-line, Fixed-Duration Nivolumab plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 50
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications 50
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 49
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications 49
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center 48
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases 48
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 48
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 48
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods 48
ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy 47
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases 47
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome 46
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study 46
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future 45
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib 43
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 43
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). 43
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data 40
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis 40
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma 40
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 40
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) 40
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases 35
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma 32
Melanoma vaccines in development 30
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 28
Ipilimumab in advanced melanoma: reports of long-lasting responses 25
IDIOTYPIC VACCIN 24
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 23
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes 23
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance 22
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability 21
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study 21
IGKV3 Proteins as Candidate "Off-the-Shelf" Vaccines for Kappa-Light Chain-Restricted B-Cell Non-Hodgkin Lymphomas 20
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type 20
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas 20
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 19
Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma 19
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients 19
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response 19
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study 18
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis 18
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: Pathogenic role and therapeutic perspectives 18
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. 18
Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes 17
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 17
Retinoic acid stabilizes p27(Kip1) in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45(Skp2) and Cks1 proteins 15
Epigenetic remodelling of DNA in cancer 15
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study 14
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone 13
MicroRNAs and dendritic cell-based vaccination in melanoma patients 13
Latent membrane protein 1 deletion mutants accumulate in Reed-Sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma 12
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia 12
Totale 3.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 203
Totale 24.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 7 0 8 0 7 9 2
2021/202257 4 4 1 2 1 2 1 9 3 4 3 23
2022/202351 6 4 1 4 9 4 1 3 8 1 8 2
2023/2024197 3 6 3 2 0 50 0 51 0 4 19 59
2024/20251.281 38 105 69 7 189 166 31 41 192 206 133 104
2025/20261.639 269 109 272 415 526 48 0 0 0 0 0 0
Totale 3.484